| scholarly article | Q13442814 |
| P50 | author | Alexei Degterev | Q90349351 |
| P2093 | author name string | Bakhos A Tannous | |
| Jonas Nilsson | |||
| Thomas Wurdinger | |||
| Michael Whalen | |||
| Christian E Badr | |||
| Johanna M Niers | |||
| P2860 | cites work | The Hallmarks of Cancer | Q221226 |
| Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule | Q24290576 | ||
| The receptor for the cytotoxic ligand TRAIL | Q24310481 | ||
| Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors | Q24310559 | ||
| TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. | Q24314730 | ||
| Subversion of cellular autophagosomal machinery by RNA viruses | Q24522711 | ||
| LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing | Q24597817 | ||
| Cytochrome c and dATP-mediated oligomerization of Apaf-1 is a prerequisite for procaspase-9 activation | Q28199391 | ||
| Tissue distribution, stability, and pharmacokinetics of Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand in human colon carcinoma COLO205 tumor-bearing nude mice | Q80391824 | ||
| Phase 1 trial of Anvirzel in patients with refractory solid tumors | Q83956808 | ||
| Classification of cell death: recommendations of the Nomenclature Committee on Cell Death | Q28278883 | ||
| Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury | Q29616008 | ||
| 3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes | Q29617843 | ||
| Mutant sodium channel for tumor therapy. | Q30481753 | ||
| A highly sensitive assay for monitoring the secretory pathway and ER stress | Q33288966 | ||
| Inhibition of the sodium potassium adenosine triphosphatase pump sensitizes cancer cells to anoikis and prevents distant tumor formation | Q33418973 | ||
| Functional drug screening assay reveals potential glioma therapeutics | Q33780121 | ||
| Real-time monitoring of nuclear factor kappaB activity in cultured cells and in animal models. | Q33795121 | ||
| Safety and antitumor activity of recombinant soluble Apo2 ligand | Q33855449 | ||
| Formation of apoptosome is initiated by cytochrome c-induced dATP hydrolysis and subsequent nucleotide exchange on Apaf-1. | Q34098735 | ||
| Targeting mTOR signaling for cancer therapy | Q34220084 | ||
| Apo2L/TRAIL and its death and decoy receptors | Q34532325 | ||
| Cardiac glycosides initiate Apo2L/TRAIL-induced apoptosis in non-small cell lung cancer cells by up-regulation of death receptors 4 and 5. | Q34533000 | ||
| Cardiac glycosides provide neuroprotection against ischemic stroke: discovery by a brain slice-based compound screening platform | Q34691557 | ||
| Novel therapeutic applications of cardiac glycosides | Q34864765 | ||
| Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway | Q34910947 | ||
| Caspase-independent cell death in T lymphocytes | Q35116688 | ||
| Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks | Q35743146 | ||
| Autophagy in metazoans: cell survival in the land of plenty | Q36146937 | ||
| The neurotoxic effects of prenatal cardiac glycoside exposure: a hypothesis. | Q36323107 | ||
| The sodium pump alpha1 subunit as a potential target to combat apoptosis-resistant glioblastomas | Q36485266 | ||
| New approaches to primary brain tumor treatment | Q36603850 | ||
| Use of APO2L/TRAIL with mTOR inhibitors in the treatment of glioblastoma multiforme | Q36614009 | ||
| A secreted luciferase for ex vivo monitoring of in vivo processes | Q37235465 | ||
| Targeting multiple pathways in gliomas with stem cell and viral delivered S-TRAIL and Temozolomide | Q37356520 | ||
| The late stages of autophagy: how does the end begin? | Q37474350 | ||
| Towards novel paradigms for cancer therapy. | Q37799251 | ||
| Proteasome inhibitors sensitize glioma cells and glioma stem cells to TRAIL-induced apoptosis by PKCε-dependent downregulation of AKT and XIAP expressions | Q39569903 | ||
| Gaussia luciferase variant for high-throughput functional screening applications | Q39816512 | ||
| Targeting the alpha 1 subunit of the sodium pump to combat glioblastoma cells | Q40008856 | ||
| Staurosporine-induced growth inhibition of glioma cells is accompanied by altered expression of cyclins, CDKs and CDK inhibitors | Q40268596 | ||
| Down-regulation of c-FLIP contributes to the sensitization effect of 3,3'-diindolylmethane on TRAIL-induced apoptosis in cancer cells. | Q40336857 | ||
| Convection-enhanced delivery of tumor necrosis factor-related apoptosis-inducing ligand with systemic administration of temozolomide prolongs survival in an intracranial glioblastoma xenograft model | Q40508031 | ||
| Intracellular ATP levels determine cell death fate by apoptosis or necrosis. | Q41110278 | ||
| Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis | Q41115305 | ||
| Inhibitors of vacuolar-type H(+)-ATPase suppresses proliferation of cultured cells | Q41510979 | ||
| Cleavage of poly(ADP-ribose) polymerase: a sensitive parameter to study cell death | Q41717170 | ||
| Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. | Q41972615 | ||
| A screen for drugs that protect against the cytotoxicity of polyglutamine-expanded androgen receptor. | Q44717221 | ||
| Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo | Q48548442 | ||
| Sensitization of human glioblastomas to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by NF-kappaB inhibitors. | Q55471801 | ||
| P433 | issue | 11 | |
| P921 | main subject | glioblastoma | Q282142 |
| P304 | page(s) | 1213-1224 | |
| P577 | publication date | 2011-07-13 | |
| P1433 | published in | Neuro-Oncology | Q15724471 |
| P1476 | title | Lanatoside C sensitizes glioblastoma cells to tumor necrosis factor-related apoptosis-inducing ligand and induces an alternative cell death pathway | |
| P478 | volume | 13 |
| Q39420743 | Assays to Monitor Autophagy Progression in Cell Cultures. |
| Q36627144 | Choroid plexus papillomas: advances in molecular biology and understanding of tumorigenesis |
| Q38960128 | Combination of systemic chemotherapy with local stem cell delivered S-TRAIL in resected brain tumors |
| Q34998829 | Compounds with species and cell type specific toxicity identified in a 2000 compound drug screen of neural stem cells and rat mixed cortical neurons |
| Q61804315 | Computational drug repurposing for inflammatory bowel disease using genetic information |
| Q28386608 | Evaluating the cancer therapeutic potential of cardiac glycosides |
| Q21996341 | Guidelines for the use and interpretation of assays for monitoring autophagy |
| Q22676705 | Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) |
| Q42577813 | Identification of Mitoxantrone as a TRAIL-sensitizing agent for Glioblastoma Multiforme |
| Q36784375 | Intracranial AAV-sTRAIL combined with lanatoside C prolongs survival in an orthotopic xenograft mouse model of invasive glioblastoma |
| Q36905850 | Lanatoside C suppressed colorectal cancer cell growth by inducing mitochondrial dysfunction and increased radiation sensitivity by impairing DNA damage repair |
| Q28535626 | Multiplex cytological profiling assay to measure diverse cellular states |
| Q45682609 | Protein-protein interaction network analysis in chronic obstructive pulmonary disease |
| Q39198894 | Regulatory effects of autophagy on spermatogenesis |
| Q28537942 | Salinomycin potentiates the cytotoxic effects of TRAIL on glioblastoma cell lines |
| Q35679830 | Systemic anticancer neural stem cells in combination with a cardiac glycoside for glioblastoma therapy |
| Q37028654 | Systemically administered AAV9-sTRAIL combats invasive glioblastoma in a patient-derived orthotopic xenograft model. |
| Q36953575 | Targeting cancer cells with the natural compound obtusaquinone. |
| Q91726670 | Targeting β2 subunit of Na+/K+-ATPase induces glioblastoma cell apoptosis through elevation of intracellular Ca2 |
| Q50977546 | The constitutive lipid droplet protein PLIN2 regulates autophagy in liver. |
| Q86927793 | The in vivo antitumor activity of cardiac glycosides in mice xenografted with human cancer cells is probably an experimental artifact |
| Q58790027 | URI knockdown induces autophagic flux in gastric cancer cells |
Search more.